Edgar Cheng
Impact in
- Oncology top 10%
- Polyomavirus and related diseases
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Co-authors
- Esteban Cvitkovic (4 shared papers)Robert B. Golbey (4 shared papers)Man H. Shiu (1 shared paper)John H. Raaf (1 shared paper)Carlos Urmacher (1 shared paper)Gordon B. Magill (12 shared papers)Willet F. Whitmore (2 shared papers)Davor Vugrin (2 shared papers)
- Journals
- Cancer (6 papers)CHEST Journal (1 paper)American Journal of Clinical Oncology (9 papers)Investigational New Drugs (1 paper)PubMed (13 papers)
- Partner nations
- United StatesRussia
In The Last Decade
Edgar Cheng
31 papers receiving 561 citations
Peers
Comparison fields: 5 of 53
- Oncology 295
- Reproductive Medicine 71
- Neurology 100
- Pulmonary and Respiratory Medicine 196
- Surgery 259
Countries citing papers authored by Edgar Cheng
This map shows the geographic impact of Edgar Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Cheng more than expected).
Fields of papers citing papers by Edgar Cheng
This network shows the impact of papers produced by Edgar Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Cheng. The network helps show where Edgar Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Edgar Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 121 | |
| 2 | 1978 | 75 | |
| 3 | 1981 | 69 | |
| 4 | 1981 | 57 | |
| 5 | 1979 | 42 | |
| 6 | 1988 | 27 | |
| 7 | Vindesine in the treatment of malignant mesothelioma: a phase II study. | 1983 | 23 |
| 8 | 1982 | 23 | |
| 9 | 1982 | 22 | |
| 10 | Phase II trial of etoposide in APUD tumors. | 1987 | 17 |
| 11 | Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. | 1982 | 17 |
| 12 | Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin. | 1985 | 16 |
| 13 | Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract. | 1985 | 13 |
| 14 | 1992 | 13 | |
| 15 | 1987 | 13 | |
| 16 | 1987 | 8 | |
| 17 | Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma. | 1984 | 8 |
| 18 | Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract. | 1983 | 8 |
| 19 | Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract. | 1984 | 8 |
| 20 | Phase II trial of ifosfamide and mesna in advanced colorectal cancer. | 1987 | 7 |
About Edgar Cheng
Edgar Cheng is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology, having authored 31 papers that have together received 620 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Lung Cancer Research Studies (6 papers), Testicular diseases and treatments (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer therapeutics and mechanisms (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (295 citations), Reproductive Medicine (71 citations), Neurology (100 citations), Pulmonary and Respiratory Medicine (196 citations) and Surgery (259 citations). Edgar Cheng has collaborated with scholars based in United States and Russia. Frequent co-authors include Esteban Cvitkovic, Robert B. Golbey, Man H. Shiu, John H. Raaf, Carlos Urmacher, Gordon B. Magill, Willet F. Whitmore, Davor Vugrin, Robert E. Wittes and Robert Golbey. Their work appears in journals such as Cancer, CHEST Journal, American Journal of Clinical Oncology, Investigational New Drugs and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.